These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8865852)

  • 1. Factor XIIIa-positive dendrocytes and proliferative activity of cutaneous cancers.
    Piérard-Franchimont C; Arrese JE; Nikkels AF; al-Saleh W; Delvenne P; Piérard GE
    Virchows Arch; 1996 Sep; 429(1):43-8. PubMed ID: 8865852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of factor XIIIa-positive dermal dendrocytes to Kaposi's sarcoma.
    Gray MH; Trimble CL; Zirn J; McNutt NS; Smoller BR; Varghese M
    Arch Pathol Lab Med; 1991 Aug; 115(8):791-6. PubMed ID: 1713758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Histologic simulators include factor XIIIa dermal dendrocytes.
    Nickoloff BJ; Griffiths CE
    Am J Pathol; 1989 Nov; 135(5):793-800. PubMed ID: 2573283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermal dendrocytes in Dupuytren's disease: a link between the skin and pathogenesis?
    Sugden P; Andrew JG; Andrew SM; Freemont AJ
    J Hand Surg Br; 1993 Oct; 18(5):662-6. PubMed ID: 7905015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XIIIa-positive dermal dendritic cells and HLA-DR expression in radial versus vertical growth-phase melanomas.
    Fullen DR; Headington JT
    J Cutan Pathol; 1998 Nov; 25(10):553-8. PubMed ID: 9870675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Von Willebrand factor receptor GPIb alpha is expressed by human factor XIIIa-positive dermal dendrocytes and is upregulated by mast cell degranulation.
    Monteiro MR; Shapiro SS; Takafuta T; Menezes DW; Murphy GF
    J Invest Dermatol; 1999 Aug; 113(2):272-6. PubMed ID: 10469316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrocytes in verruga peruana and bacillary angiomatosis.
    Arrese Estrada J; Piérard GE
    Dermatology; 1992; 184(1):22-5. PubMed ID: 1348435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral submucosal dendrocytes: factor XIIIa+ and CD34+ dendritic cell populations in normal tissue and fibrovascular lesions.
    Regezi JA; Nickoloff BJ; Headington JT
    J Cutan Pathol; 1992 Oct; 19(5):398-406. PubMed ID: 1282135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased submucosal factor XIIIa-positive dendrocytes in oral lichen planus.
    Regezi JA; Daniels TE; Saeb F; Nickoloff BJ
    J Oral Pathol Med; 1994 Mar; 23(3):114-8. PubMed ID: 7517451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dermal dendrocytes and factor XIIIa in normal and pathological skin].
    Cerio R
    Ann Dermatol Venereol; 1993; 120(1):53-7. PubMed ID: 8101702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulatory function of factor-XIIIa-positive dendrocytes in incipient toxic epidermal necrolysis and graft-versus-host reaction. A hypothesis.
    Hermanns-Lê T; Paquet P; Piérard-Franchimont C; Arrese JE; Piérard GE
    Dermatology; 1999; 198(2):184-6. PubMed ID: 10325477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells and dendritic cells in basal cell carcinoma stroma.
    Humphreys TR; Monteiro MR; Murphy GF
    Dermatol Surg; 2000 Mar; 26(3):200-3; discussion 203-4. PubMed ID: 10759793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermal dendrocytes participate in the cellular pathology of experimental acute graft-versus-host disease.
    Yoo YH; Park BS; Whitaker-Menezes D; Korngold R; Murphy GF
    J Cutan Pathol; 1998 Sep; 25(8):426-34. PubMed ID: 9826168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dendrocyte population in cutaneous and extracutaneous Kaposi's sarcoma.
    Kumar D; Sánchez RL; Kumar S
    Am J Dermatopathol; 1992 Aug; 14(4):298-303. PubMed ID: 1354417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 12E2: a cloned murine dermal cell with features of dermal dendrocytes and capacity to produce pathologic changes resembling early Kaposi's sarcoma.
    Deguchi M; Whitaker-Menezes D; Jones SC; Aiba S; Nakagawa S; Tagami H; Korngold R; Murphy GF
    Am J Pathol; 2003 Nov; 163(5):1817-25. PubMed ID: 14578182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIIIa-positive dendrocytes in malignant melanoma.
    Piérard-Franchimont C; Piérard GE
    J Cutan Pathol; 1999 May; 26(5):263-4. PubMed ID: 10408353
    [No Abstract]   [Full Text] [Related]  

  • 17. Imiquimod-responsive basal cell carcinomas and factor XIIIa-enriched dendrocytes.
    Quatresooz P; Piérard GE
    Clin Exp Dermatol; 2003 Nov; 28 Suppl 1():27-9. PubMed ID: 14616809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histiocytoma cutis: a tumour of dermal dendrocytes (dermal dendrocytoma).
    Cerio R; Spaull J; Jones EW
    Br J Dermatol; 1989 Feb; 120(2):197-206. PubMed ID: 2564281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemical localization of a novel beta 1 integrin in normal and pathologic squamous epithelia.
    Cerri A; Favre A; Giunta M; Corte G; Grossi CE; Berti E
    J Invest Dermatol; 1994 Feb; 102(2):247-52. PubMed ID: 7508965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel interactions between dermal dendrocytes and mast cells in human skin. Implications for hemostasis and matrix repair.
    Sueki H; Whitaker D; Buchsbaum M; Murphy GF
    Lab Invest; 1993 Aug; 69(2):160-72. PubMed ID: 8102416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.